Acute ischemic stroke

21 total trials 10 recruiting

Filter these 21 trials by phase, country, sponsor and more.

Open in Search →

An Open-label Phase 2b Study with Blinded Evaluation of the Combination of Amodiaquine and Potassium Canrenoate with Exenatide or Glibenclam … Not authorised

2025-522796-28-00 4
A randomized, placebo-controlled, double-blind, single-ascending-dose, Phase 1a/b study to assess the safety, pharmacokinetics, pharmacodyna … Pending

2024-512196-12-00 1
MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study Pending

2024-517600-11-01 5
A randomized placebo-controlled double-blind trial phase II two-arm study to investigate infarct growth over 72 hours assessed with diffusio … Pending

2025-521269-28-00 4
A study to test if tenecteplase helps people to recover from an acute stroke when given more than 4.5 hours after the person was last seen w … Pending

2025-522542-40-00 5
SAVE trial Pending

2025-523709-13-00 5
A study to learn if DM199 drug is safe and whether it works better than placebo for treating acute ischemic stroke Recruiting

2024-513911-28-00 10 2026-03-04
Evaluation of Novel Thrombolytic TGD001 in Patients With Acute Ischemic Stroke Recruiting

2025-522455-26-00 9 2025-12-17
Reperfusion with P2Y12 inhibitors in addition to mechanical thrombectomy for perfusion imaging selected acute stroke patients : a multicentr … Recruiting

2024-516163-88-00 11 2024-08-01
A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke Recruiting

2022-501890-38-00 4 2024-02-16
Local Tenecteplase ApplicatiOn subsequent to endovasCular Recanalization in Anterior CircuLation Stroke - the LOCAL trial Recruiting

2024-516544-26-00 4 2026-03-30
Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants Recruiting

2025-521762-99-00 5 2026-03-09
Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION) Recruiting

2024-519521-37-01 10 2025-07-30
Thrombolysis in Factor Xa-inhibitors Trial (SIFT) Recruiting

2023-509907-34-01 5 2025-03-10
General anesthesia versus sedation with high-flow nasal cannula for the endovascular treatment of acute ischemic stroke Recruiting

2024-510752-12-00 6 2024-11-13
A multicentre study evaluating the safety of reperfusion thrombolytic therapy with intravenous recombinant tissue plasminogen activator (rtP … Recruiting

2024-518509-17-00 4 2022-01-10
A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke Halted

2023-506178-11-00 5 2025-11-11
Glenzocimab for REperfusion in the setting of Endovascular therapy for brain infarctioN Ended

2024-514352-32-00 10 2023-01-03
A first-in-human study to learn how safe the study treatment BAY3018250 is, how it affects the body, how it moves into, through, and out of … Ended

2022-500505-41-00 1 2022-11-08
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended

2023-508454-26-00 6 2022-05-01
HOPE study Ended

2024-516642-19-01 6 2021-06-16

Showing 1–21 of 21 trials